{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:15:44Z","timestamp":1778883344840,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/13\/25\/2020\/NCD- III"],"award-info":[{"award-number":["5\/13\/25\/2020\/NCD- III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bbrep.2025.102104","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T13:40:26Z","timestamp":1750686026000},"page":"102104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Altered dynamics of T cell subsets in peripheral blood impacts disease progression in newly diagnosed multiple myeloma"],"prefix":"10.1016","volume":"43","author":[{"given":"Mohini","family":"Vig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0457-9692","authenticated-orcid":false,"given":"Shweta","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5364-4086","authenticated-orcid":false,"given":"Ritu","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2025.102104_bib1","author":"Albagoush"},{"issue":"Supplement 1","key":"10.1016\/j.bbrep.2025.102104_bib2","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2023-188244","article-title":"Multiple myeloma and DALY in the USA: insights of the global burden of disease","volume":"142","author":"Cuartas","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.bbrep.2025.102104_bib3","series-title":"Statistical Systems: Health","first-page":"15066","author":"Leadbeter","year":"2001"},{"issue":"9","key":"10.1016\/j.bbrep.2025.102104_bib4","doi-asserted-by":"crossref","first-page":"e670","DOI":"10.1016\/S2352-3026(22)00165-X","article-title":"The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends","volume":"9","author":"Huang","year":"2022","journal-title":"Lancet Haematol"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102104_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/nyas.13038","article-title":"Multiple myeloma in the marrow: pathogenesis and treatments","volume":"1364","author":"Fairfield","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbrep.2025.102104_bib6","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.3390\/ijms23095242","article-title":"The role of T cell immunity in monoclonal gammopathy and multiple myeloma: from immunopathogenesis to novel therapeutic approaches","volume":"23","author":"Lagreca","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bbrep.2025.102104_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/ejh.13839","article-title":"The evolution of immune dysfunction in multiple myeloma","volume":"109","author":"Soekojo","year":"2022","journal-title":"Eur J Haematol [Internet]"},{"issue":"6","key":"10.1016\/j.bbrep.2025.102104_bib8","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.immuni.2012.08.021","article-title":"Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory","volume":"37","author":"Doering","year":"2012","journal-title":"Immunity [Internet]"},{"issue":"8","key":"10.1016\/j.bbrep.2025.102104_bib9","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol [Internet]"},{"issue":"8","key":"10.1016\/j.bbrep.2025.102104_bib10","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1038\/leu.2016.84","article-title":"Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade","volume":"30","author":"Suen","year":"2016","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.bbrep.2025.102104_bib11","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1158\/1078-0432.CCR-19-2111","article-title":"How to train your T cells: overcoming immune dysfunction in multiple myeloma a C","volume":"26","author":"Cohen","year":"2020","journal-title":"Clinical Cancer Research [Internet]"},{"issue":"2","key":"10.1016\/j.bbrep.2025.102104_bib12","article-title":"The role of chimeric antigen Receptor-T cell therapy in the treatment of hematological malignancies: advantages, trials, and tribulations, and the road ahead","volume":"13","author":"Reddy","year":"2021","journal-title":"Cureus"},{"issue":"23","key":"10.1016\/j.bbrep.2025.102104_bib13","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1200\/JCO.2015.65.9789","article-title":"Nivolumab in patients with relapsed or refractory hematologic malignancy: preliminary results of a phase Ib study","volume":"34","author":"Lesokhin","year":"2016","journal-title":"J Clin Oncol [Internet]"},{"issue":"12","key":"10.1016\/j.bbrep.2025.102104_bib14","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International myeloma working group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbrep.2025.102104_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.720932","article-title":"Does ethnicity matter in multiple myeloma risk prediction in the era of genomics and novel agents? Evidence from real-world data","volume":"11","author":"Farswan","year":"2021","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.bbrep.2025.102104_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101157","article-title":"AI-supported modified risk staging for multiple myeloma cancer useful in real-world scenario","volume":"14","author":"Farswan","year":"2021","journal-title":"Transl. Oncol."},{"issue":"7","key":"10.1016\/j.bbrep.2025.102104_bib18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/cyto.a.24738","article-title":"OMIP-91: a 27-color flow cytometry panel to evaluate the phenotype and function of human conventional and unconventional T-cells","volume":"103","author":"Anderson","year":"2023","journal-title":"Cytometry A"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102104_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/cyto.a.24799","article-title":"OMIP-099: 31-Color spectral flow cytometry panel to investigate the steady-state phenotype of human T cells","volume":"105","author":"Zacharias","year":"2024","journal-title":"Cytometry A"},{"issue":"8","key":"10.1016\/j.bbrep.2025.102104_bib20","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1080\/10428194.2020.1751840","article-title":"Low absolute CD4+ T cell counts in peripheral blood predict poor prognosis in patients with newly diagnosed multiple myeloma","volume":"61","author":"Gu","year":"2020","journal-title":"Leuk Lymphoma [Internet]"},{"key":"10.1016\/j.bbrep.2025.102104_bib21","article-title":"Clinical significance of T helper cell subsets in the peripheral blood and bone marrow of patients with multiple myeloma","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bbrep.2025.102104_bib22","first-page":"1876","article-title":"[Correlation of Peripheral Blood T Lymphocyte Subsets with Prognosis of Elderly Patients with Newly Diagnosed Multiple Myeloma]","volume":"27","author":"Ding","year":"2019","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"8","key":"10.1016\/j.bbrep.2025.102104_bib23","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1080\/10428194.2020.1779261","article-title":"Exhausted and outnumbered: CD4+ T cells in the myeloma battlefield","volume":"61","author":"Manasanch","year":"2020","journal-title":"Leuk Lymphoma [Internet]"},{"issue":"8","key":"10.1016\/j.bbrep.2025.102104_bib24","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1080\/10428194.2020.1751840","article-title":"Low absolute CD4+ T cell counts in peripheral blood predict poor prognosis in patients with newly diagnosed multiple myeloma","volume":"61","author":"Gu","year":"2020","journal-title":"Leuk Lymphoma [Internet]"},{"issue":"6","key":"10.1016\/j.bbrep.2025.102104_bib25","first-page":"1","article-title":"Immune system alterations in multiple myeloma: molecular mechanisms and therapeutic strategies to reverse immunosuppression","volume":"13","author":"D\u00edaz-Tejedor","year":"2021","journal-title":"Cancers (Basel) [Internet]"},{"issue":"11","key":"10.1016\/j.bbrep.2025.102104_bib26","article-title":"Early alterations in stem-like\/marrow-resident T cells and innate and myeloid cells in preneoplastic gammopathy","volume":"4","author":"Bailur","year":"2019","journal-title":"JCI Insight [Internet]"},{"issue":"5","key":"10.1016\/j.bbrep.2025.102104_bib27","first-page":"e266","article-title":"Increased exhausted CD8 + T cells with programmed death-1, T-cell immunoglobulin and mucin-domain-containing-3 phenotype in patients with multiple myeloma","volume":"14","author":"Tan","year":"2018","journal-title":"Asia Pac J Clin Oncol [Internet]"},{"issue":"4","key":"10.1016\/j.bbrep.2025.102104_bib28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-2567.2010.03255.x","article-title":"T-cell exhaustion: characteristics, causes and conversion","volume":"129","author":"Yi","year":"2010","journal-title":"Immunology [Internet]"},{"issue":"8","key":"10.1016\/j.bbrep.2025.102104_bib29","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol [Internet]"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102104_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbmt.2019.08.009","article-title":"T cell transcriptional profiling and immunophenotyping uncover LAG3 as a potential significant target of immune modulation in multiple myeloma","volume":"26","author":"Lucas","year":"2019","journal-title":"Biol Blood Marrow Transplant [Internet]"},{"issue":"3","key":"10.1016\/j.bbrep.2025.102104_bib31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.20021683","article-title":"Immunotherapy of cytotoxic T cell\u2013resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process","volume":"197","author":"Mattes","year":"2003","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102104_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-25282-3","article-title":"Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity","volume":"12","author":"Weigelin","year":"2021","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102104_bib33","article-title":"Role of immune cells and immunotherapy in multiple myeloma","volume":"14","author":"Radhakrishnan","year":"2024","journal-title":"Life [Internet]"},{"issue":"5","key":"10.1016\/j.bbrep.2025.102104_bib34","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: co-Inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"issue":"17","key":"10.1016\/j.bbrep.2025.102104_bib35","article-title":"Deregulated expression of immune checkpoints on circulating cd4 t cells May complicate clinical outcome and response to treatment with checkpoint inhibitors in multiple myeloma patients","volume":"22","author":"de Na\u0142\u0119cz","year":"2021","journal-title":"Int J Mol Sci [Internet]"},{"issue":"9","key":"10.1016\/j.bbrep.2025.102104_bib36","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.clml.2024.04.006","article-title":"T cell exhaustion markers in multiple myeloma patients are lower after physical activity intervention","volume":"24","author":"Joseph","year":"2024","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102104_bib37","article-title":"Immune checkpoint inhibitors for multiple myeloma immunotherapy","volume":"12","author":"Liu","year":"2023","journal-title":"Exp Hematol Oncol [Internet]"},{"issue":"19","key":"10.1016\/j.bbrep.2025.102104_bib38","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.3390\/jcm10194588","article-title":"Regulatory T-Cells and multiple myeloma: implications in tumor immune biology and treatment","volume":"10","author":"Hadjiaggelidou","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102104_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-023-01765-8","article-title":"What happens to regulatory T cells in multiple myeloma","volume":"9","author":"Chen","year":"2023","journal-title":"Cell Death Discov."},{"issue":"6","key":"10.1016\/j.bbrep.2025.102104_bib40","doi-asserted-by":"crossref","DOI":"10.1007\/s10753-012-9496-8","article-title":"CD4(+)CD25 (+)CD127 (low\/-) T cells: a more specific treg population in human peripheral blood","volume":"35","author":"Yu","year":"2012","journal-title":"Inflammation"},{"issue":"suppl 1","key":"10.1016\/j.bbrep.2025.102104_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/eht309.P4177","article-title":"Homeostatic shift and deficient function of naive and memory regulatory T cells in patients with coronary artery disease","volume":"34","author":"Hasib","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbrep.2025.102104_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.804919","article-title":"Th17\/Treg imbalance in chronic obstructive pulmonary disease: clinical and experimental evidence","volume":"12","author":"Louren\u00e7o","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.bbrep.2025.102104_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa112","article-title":"Restoring regulatory T-cell dysfunction in Alzheimer's disease through ex vivo expansion","volume":"2","author":"Faridar","year":"2020","journal-title":"Brain Commun"},{"issue":"7","key":"10.1016\/j.bbrep.2025.102104_bib44","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2153534","article-title":"Regulatory T cell therapy for multiple sclerosis: breaching (blood-brain) barriers","volume":"18","author":"Verreycken","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"10.1016\/j.bbrep.2025.102104_bib45","article-title":"Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death","volume":"108","author":"Fritzsching","year":"2006","journal-title":"Blood [Internet]"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102104_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030422","article-title":"In vivo expansion of na\u00efve CD4+CD25high FOXP3+ regulatory T cells in patients with colorectal carcinoma after IL-2 administration","volume":"7","author":"Beyer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2025.102104_bib47","author":"Brenna"},{"issue":"7","key":"10.1016\/j.bbrep.2025.102104_bib48","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1084\/jem.20161794","article-title":"Vaccination establishes clonal relatives of germinal center T cells in the blood of humans","volume":"214","author":"Heit","year":"2017","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102104_bib49","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2337\/db16-0714","article-title":"Circulating CXCR5+PD-1+ICOS+ follicular T helper cells are increased close to the diagnosis of type 1 diabetes in children with multiple autoantibodies","volume":"66","author":"Viisanen","year":"2017","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.bbrep.2025.102104_bib50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.29252\/ibj.25.2.117","article-title":"Frequency of efficient circulating follicular helper T cells correlates with dyslipidemia and WBC count in atherosclerosis","volume":"25","author":"Talepoor","year":"2021","journal-title":"Iran Biomed J [Internet]"},{"issue":"4","key":"10.1016\/j.bbrep.2025.102104_bib51","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.trecan.2022.12.007","article-title":"T follicular helper cells in cancer","volume":"9","author":"Guti\u00e9rrez-Melo","year":"2023","journal-title":"Trends Cancer"},{"issue":"8","key":"10.1016\/j.bbrep.2025.102104_bib52","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol [Internet]"},{"issue":"3","key":"10.1016\/j.bbrep.2025.102104_bib53","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cell.2016.12.022","article-title":"Systemic immunity is required for effective cancer immunotherapy","volume":"168","author":"Spitzer","year":"2017","journal-title":"Cell [Internet]"},{"issue":"8","key":"10.1016\/j.bbrep.2025.102104_bib54","article-title":"Lessons learned from checkpoint blockade targeting PD-1 in multiple myeloma","volume":"7","author":"Lesokhin","year":"2019","journal-title":"Cancer Immunol Res [Internet]"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102104_bib55","article-title":"Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy","volume":"16","author":"Cai","year":"2023","journal-title":"J Hematol Oncol [Internet]"},{"issue":"3","key":"10.1016\/j.bbrep.2025.102104_bib56","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2016-08-731885","article-title":"Targeting the PD-1\/PD-L1 axis in multiple myeloma: a dream or a reality?","volume":"129","author":"Rosenblatt","year":"2017","journal-title":"Blood"}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825001918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825001918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:46:19Z","timestamp":1778881579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580825001918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":55,"alternative-id":["S2405580825001918"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102104","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered dynamics of T cell subsets in peripheral blood impacts disease progression in newly diagnosed multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102104"}}